These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6488198)

  • 21. Treatment of tardive dyskinesia with bromocriptine. A test of the receptor modification strategy.
    Lieberman JA; Alvir J; Mukherjee S; Kane JM
    Arch Gen Psychiatry; 1989 Oct; 46(10):908-13. PubMed ID: 2572205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrabenazine and movement disorders.
    Asher SW; Aminoff MJ
    Neurology; 1981 Aug; 31(8):1051-4. PubMed ID: 6455607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyproheptadine in levodopa-induced dyskinesia in parkinsonism.
    Papavasilliou PS; Cotzias GC; McDowell FH; Rosal VL; Sheehan PJ
    Clin Pharmacol Ther; 1978 Feb; 23(2):195-8. PubMed ID: 620480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.
    Suzuki T; Matsuzaka H
    CNS Drugs; 2002; 16(3):165-74. PubMed ID: 11888337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxiperomide in tardive dyskinesia.
    Casey DE; Gerlach J
    J Neurol Neurosurg Psychiatry; 1980 Mar; 43(3):264-7. PubMed ID: 7373324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of tardive and spontaneous dyskinesias with corticosteroids.
    Benecke R; Conrad B; Klingelhöfer J
    Eur Neurol; 1988; 28(3):146-9. PubMed ID: 2898365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of combined L-dopa and central anticholinergic in a patient with severe drug-induced parkinsonism and tardive dystonia.
    Looper KJ; Chouinard G
    Can J Psychiatry; 1998 Aug; 43(6):646-7. PubMed ID: 9729698
    [No Abstract]   [Full Text] [Related]  

  • 30. Diltiazem for tardive dyskinesia and tardive dystonia.
    Falk WE; Wojick JD; Gelenberg AJ
    Lancet; 1988 Apr; 1(8589):824-5. PubMed ID: 2895341
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine.
    Bouckaert F; Herman G; Peuskens J
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):287-8. PubMed ID: 15770692
    [No Abstract]   [Full Text] [Related]  

  • 32. Remission of irreversible aripiprazole-induced tardive dystonia with clozapine: a case report.
    Joe S; Park J; Lim J; Park C; Ahn J
    BMC Psychiatry; 2015 Oct; 15():253. PubMed ID: 26482558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between tardive dyskinesia, L-Dopa-induced hyperkinesia and parkinsonism.
    Gerlach J
    Psychopharmacology (Berl); 1977 Mar; 51(3):259-63. PubMed ID: 403541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of clonidine in tardive dystonia: implications for nosology.
    Adityanjee ; Singh S; Subramaniam M
    Biol Psychiatry; 1989 Jun; 26(2):199-202. PubMed ID: 2567611
    [No Abstract]   [Full Text] [Related]  

  • 35. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of clozapine in tardive dystonia.
    Van Harten PN; Kampuis DJ; Matroos GE
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Feb; 20(2):263-74. PubMed ID: 8861192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bromocriptine in tardive dyskinesia.
    Häggström JE; Andersson U; Gunne LM
    Pharmacopsychiatria; 1982 Sep; 15(5):161-3. PubMed ID: 6129649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In search of treatment for tardive dyskinesia: review of the literature.
    Jeste DV; Wyatt RJ
    Schizophr Bull; 1979; 5(2):251-93. PubMed ID: 37597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
    Jankovic J; Orman J
    Neurology; 1988 Mar; 38(3):391-4. PubMed ID: 3279337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
    Bathien N; Rondot P; Koutlidis RM
    J Physiol (Paris); 1981 Apr; 77(1):131-41. PubMed ID: 6112268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.